India's animal healthcare market is a ₹7,000 crore opportunity. Understand the landscape, species distribution, and where Greenvet sits within it.
INFAH data shows Nutritionals dominating at 39% — the exact segment Greenvet's G-Lite, GVIT-H, Greemin-Gold, and G-Liv DS address.
Source: INFAH · pashudhanpraharee
Livestock commands 55% — confirming Greenvet's cattle-first approach is targeting the largest, highest-value segment.
India's rapidly growing dairy sector, rising farmer awareness, and government livestock health schemes are driving strong demand for quality, affordable veterinary medicines year over year.
Greenvet operates across Nutritionals (39%), Antibacterials (17%), and Parasiticides (20%) — the three largest AH product categories — positioning it squarely in the highest-demand market segments.
With 55% of India's AH market being livestock-focused, cattle health solutions directly impact the income and livelihoods of millions of farmers — making Greenvet's mission both commercially and socially significant.
Individual and organized dairy farmers seeking reliable, affordable veterinary solutions to maximize herd productivity, milk yield, and reproductive performance.
Practicing veterinarians and animal hospitals requiring trusted pharmaceutical products with strong clinical evidence for diagnosis, treatment, and prevention.
Dairy federations and rural cooperatives responsible for the health management of large cattle populations across villages and districts.